chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID+ 11/24/22.  Vaccination status - pfizer x4 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Physician at Discharge: MD Admission Date: 11/24/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Chronic bilateral pleural effusions 11/25/2022 Yes ? Open wound of dorsum of foot 11/25/2022 Unknown ? Counseling regarding advance care planning and goals of care 11/25/2022 Unknown ? Septic shock 11/24/2022 Yes ? COVID-19 virus infection 11/24/2022 Yes ? Anasarca 11/24/2022 Yes ? Open wound of left foot 11/24/2022 Yes ? Acute respiratory failure with hypoxia and hypercapnia 11/24/2022 Yes ? Medication induced coagulopathy 11/24/2022 Yes ? AKI (acute kidney injury)    DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Septic shock    HOSPITAL COURSE: 78 y/o male with past medical history significant for HTN, Afib for which he is on Coumadin s/p pacemaker placement, PVD. He presented to ED 11/24 with one week history of weakness and recent falls. Family was unable to get him out of bed and called EMS. In the ED, patient denied any focal complaints but it was noted that 2 of his family members with whom he lives recently tested positive for COVID. Of note, patient has been recently treated with antibiotics for a foot infection.    Upon arrival to ED, patient was noted to be hypothermic/hypotensive/hypoxic. His oxygen requirements quickly escalated to requiring HFNC. Initial gas noted to be 7.27/66.5/145.2. Labs were notable for AKI with a Cr of 1.92 (baseline around 1-1.2), pro-bnp of 4663, initial troponin of 69, LA-2.7 which subsequently normalized to 1.9, normal PCT, and WBC-3.56. INR was elevated at >8 with stable Hg of 15 and no reported bleeding. COVID (+). UA unremarkable. EKG demonstrated ventricular paced rhythm with prolonged Qtc. CTH was negative for any acute abnormalities. CXR showed cardiomegaly with pulmonary vascular congestion as well as bilateral pleural effusions and patchy midlung opacities. Right basilar atelectasis or PNA was also reported. Patient was ultimately transitioned to Bipap with improvement in his respiratory status. Patient was given 250 ml of IVFs and then transitioned to NE gtt due to concerns of fluid overload. He additionally received Rocephin, Doxycycline, 10 mg of IV decadron, 40 mg IV lasix, and 2.5 mg PO of Vitamin K. He was then transferred to ICU for further care.   CT thorax 11/24 with bilateral pleural effusions, partially loculated. INR reversed and patient received left sided thoracentesis with right pleural drain. IR also performed diagnostic paracentesis for noted ascites on CT. Pleural fluid noted to be transudative, no signs of SBP in ascitic fluid. Renal function worsening with poor urine output. Following discussions with family patient transitioned to DNR/DNI. He was transitioned to comfort care 11/26 and pronounced deceased at 2110 11/26/23
Almost immediately after injection I had chest pain and felt my heart rate increase. This was temporary and lasted max 10 minutes.  Then in the middle of the night that night I developed swelling and redness at the injection site as well as head to toe body aches and fatigue.  By mid day Tuesday 4/6/21 the redness at the injection site developed into an irregularly shaped red rash that extended from deltoid almost to elbow and was hot to the touch and I developed a fever that lasted until Friday ( highest it got was 102.1F) All other symptoms resolved Sunday  4/11/21
Shaking, Shivering and Very Cold; Shaking, Shivering and Very Cold; Shaking, Shivering and Very Cold; This is a spontaneous report from a contactable physician. An 18-year-old female patient received first dose of meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration in Jun2019 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The physician wanted to know if it's okay to give second dose if patient reporting shivering after first dose. The patient received her first dose about a month ago (Jun2019). She was fine while in the office. When she got home, the mother called reporting that patient was shaking, shivering, and very cold. This lasted about 30-40 minutes and then she was fine. The patient recovered from the events on an unspecified date in Jun2019.   Information on the batch number has been requested.
I was diagnosed by my neurologist with Guillain-Barre Syndrome.  9 days after my 2nd Pfizer shot (Sunday, March 28th), I felt tingling in my feet. On Monday night I felt tingling and pain in my feet, but I was sure it was passing and said nothing since the pain was manageable at a level 2?3. On Tuesday I was getting concerned. My feet were now tingling and in pain all day, and the pain had escalated to a level 5. On Wednesday I suddenly realized that my life could effectively be over soon. The pain was at a 7-8, and I could barely get through my day. My body felt like there were tiny needles shooting electricity into me, and it felt all-consuming. It was unrelenting, and I suddenly understood why the CEO (a COVID survivor) killed himself after suffering through constant ringing in his ears. It became CRYSTAL clear how chronic pain made regular working life impossible, and I wondered how I would get by on disability and how long it would take to kick in after applying. I started panicking while focusing enough to book a doctor?s appointment for that Friday. By the end of Wednesday my calves and thighs were severely cramped, and by Thursday my eyes were tingling and my hands and arms were tingling with pain. I feared MS since it runs in my family. I was terrified and confused and made an appointment with a PCP for Friday, April 2nd.
Shoulder pain starting shortly after receiving shot. Injection given too high, into shoulder. Pain goes from back left shoulder blade down to left elbow. Holding shoulder forward with difficulty moving back to proper location. Limit and stiff range of motion and strength. Starting physical therapy per drs recommendation and taking oral steroids currently.
Client stated she felt lightheaded after receiving her vaccine.  Vital signs obtained: BP 117/81, HR 74, O2 sat 98%.
Patient developed hives on her face and back after receiving FLUMIST (about 15 min after administration). Patient seen, epipen administered, BENADRYL 5ml given. Patient observed.
Severe ankle pain in the left foot.; It's like it was a strain that just became worse after six hours; This is a spontaneous report from a contactable consumer (patient) via COVAES. A 23-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 02Jul2021 at 17:30 (Batch/Lot Number: EW0196) (at the age of 23-years old) as dose number unknown, single for COVID-19 immunisation. The patient had no medical history. The patient had no reported allergies. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 post vaccination. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks of COVID-19 vaccine. The patient experienced severe ankle pain in the left foot, it was like it was a strain that just became worse after six hours on 04Jul2021 at 16:00. It was unknown if the patient received any treatment for the events. The outcome of events was not recovered.  No follow-up activities are possible. No further information is expected.
6-inch by 6-inch raised rash. Looks like large hives. COVID arm.
I started exhibiting symptoms of shingles within hours of receiving my first vaccination. I was not aware of what the symptoms were at the time as I was not immediately in pain or discomfort, but a rash did start to appear on the right side of my torso and back only. After almost 48 hours of no improved state, I scheduled a visit to a different Pharmacy with a Clinic to be seen. The nurse practitioner on staff told me it was shingles almost immediately after I showed her my right side. I was given a pill to take daily and an antibiotic to apply daily as well. Because I was able to get medicine not long after symptoms showed, the shingles was limited to my right side/midsection. I continued taking the antiviral pills for 10 days. I also used the antibiotic for a total of 14 days and kept my midsection covered and cleaned consistently as recommended.
First shingles outbreak January 2018 left buttock. First SHINGRIX dose 5/15/2018 left deltoid. Second SHINGRIX dose 8/1/2018 left deltoid. Second shingles outbreak approximately 9/30/2018 left buttock, smaller area than first outbreak. Continued sensitivity in that location currently.
Evening of 5/8/05, mother noted red, hard, warm mass on right deltoid 5x3cm, marked off in pen, less redness, now flat and nontender on exam 5/9/05 with clear areas inside marked off 5x3cm.
Suffered severe incident twice; Dementia; Showing a maniac behavior; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Suffered severe incident twice), DEMENTIA (Dementia) and MANIA (Showing a maniac behavior) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D2LA) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism and Blood pressure high. Concomitant products included HYDROCHLOROTHIAZIDE and SPIRONOLACTONE for Blood pressure high, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.    On 28-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2021, the patient experienced DEMENTIA (Dementia). 29-Aug-2021, the patient experienced MANIA (Showing a maniac behavior). On an unknown date, the patient experienced VACCINATION COMPLICATION (Suffered severe incident twice). On 29-Aug-2021, DEMENTIA (Dementia) and MANIA (Showing a maniac behavior) had resolved. At the time of the report, VACCINATION COMPLICATION (Suffered severe incident twice) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was provided.   This case was linked to MOD-2021-301073, MOD-2021-300955 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Adverse event updated to suffered severe incident twice On 03-Sep-2021: Follow-up received on 03-Sep-2021 and No New Information is provided.
Following booster shot (roughly two months), I started to experience headaches, extreme fatigue, visual distortions, pulsatile tinnitus, near fainting, and other symptoms. Eventually a doctor ordered a blood test and I was admitted to emergency care while traveling. I was given several blood transfusions and returned immediately home. I have since undergone several different tests , including bone marrow biopsy which reveals a diagnosis of Pure Red Cell Aplasia. All known forms of cause of this have been tested and ruled out.  I continue to struggle with this condition and am on daily medication in attempt to control it. I have no history of blood disorders.
This is a spontaneous report from a contactable consumer or other non hcp. A 6-decade-old male patient (in in his late 50s) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, (Batch/Lot number was not reported)), via an unspecified route of administration on an unspecified date earlier in 2021 as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with the pfizer covid-19 vaccine earlier in 2021. He just recently tested positive for covid on an unspecified date in 2021. Event took place after use of product. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive on 2021 tested positive for COVID. The outcome of the event was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt got the Janssen (Johnson and Johnson) vaccine on 4/3/2021, and today on 4/13/2021 he reported to us that he had a systematic rash though out his body. We saw rashes on his arm and torso.  He also reported bumps on his torso and arms as well.
Headache, Myalgia, Arthralgia, NauseaVomiting, fatigue
within 4 minutes of receiving vaccine, client reported feeling light headed. We reclined her in her car seat and she stayed like that for 4 minutes. she then stated feeling nauseous. She sat back up and reported feeling short of breath, and that it was hard to swallow. After consulting another monitoring staff member, epinephrine was given in left thigh at 11:24 am, and EMS was called, hand off given to EMS upon arrival. First vitals check was 151/78 BP, 98% O2, 160 bpm HR, and 26 breaths per minute. At 11:27am  second vitals set showed 141/75 BP and 152 bpm HR, third set of vitals before EMS hand off was 130/73 BP and 141 bpm HR, RR was 24 and O2% was 99.
This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE, CHILLS, FATIGUE, BURNING SENSATION, and PRURITUS in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event, No reported medical history. Concomitant products included ROSUVASTATIN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HEADACHE. On 13-Feb-2021, the patient experienced CHILLS and FATIGUE. On 19-Feb-2021, the patient experienced BURNING SENSATION. On 21-Feb-2021, the patient experienced PRURITUS. On 26-Feb-2021, the patient experienced BURNING SENSATION and PRURITUS. On 12-Feb-2021, HEADACHE had resolved. On 14-Feb-2021, CHILLS and FATIGUE had resolved. On 12-Mar-2021, BURNING SENSATION, PRURITUS, BURNING SENSATION, and PRURITUS had resolved. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was treated with hydrocortisone cream.
Information has been received from a physician concerning a 71 year old male consumer who on 16-NOV-2007 was vaccinated subcutaneous with ZOSTAVAX.  Concomitant therapy included "some cholesterol medications".  Subsequently, the patient experienced "radicular pain on the side where he received the vaccine."  On 23-NOV-2007 the patient was "back in the clinic" with this pain.  He was "eventually" diagnosed with brachial plexopathy after further testing.  At the time of the report the patient was still weak in his arm, but was recovering.  There was no product quality complaint involved.  Follow-up information has been received from the physician concerning this 71 year old male consumer with sulfonamide and neomycin allergies who on 16-NOV-2007 was vaccinated SQ in the left arm with a first dose of ZOSTAVAX (lot # 658838/1412U).  Concomitant vaccination included an eighth dose of FLUZONE (lot #U2457AA) IM in the left arm.  There was no illness at the time of vaccination.  On 19-NOV-2007 the patient was assessed by a neurologist and diagnosed with brachial plexopathy.  An EMG in December 2007 confirmed the diagnosis.  In March 2008 the patient recovered from left brachial plexopathy according to his EMG results.  It was also reported that the patient had manifested left shoulder abductor weakness.  At the time of the report the patient was improving.  Additional information has been requested.
Rash all over, edema, fever 103.  Prednisone resolved temporarily.  Renewed rash, intermittent fever, chills, vomiting, itching, edema in extremeties, pleurisy, fluid in lungs, ground-glass images in lungs.    I don't know if any of this is related to the vaccine.    I have since had Moderna vaccines on 4/6/2021, 10/22/2021 and 4/4/2022.  My arm was sore for a few days after each shot, but I did not experience any other immediate symptoms.
Patient called and left a phone message for the VP of a clinic on 09/30/2021.   I was able to retunr his call on 09/30/2021 at 6pm.  He stated that after receiving the 1st COVID  vaccine he left the event place and got a cup of coffee.  He said the coffee didn't taste the same as usual, and this was his first symptom.  He had no other symptoms, so he returned and took at 2nd COVID vaccine on 02/26/21.   He stated approximately 30 days after the 2nd vaccine his symptoms began exacerbating.  He experienced loss of appetite, eventually losing more than 12 pounds.   He reported 30 days after the 2nd vaccine he had trouble sleeping at night, crazy dreams.  He also said he had a burning sensation from his chest down to his pelvic area- an intense internal heat, and he was not febrile by the thermometer.   He states he has spent thousands of dollars going to doctors and specialists and he still doesn't have an answer to what is going on.  He told me all of his tests and lab works have been negative- he could not tell me what tests or labs he had done.  He did state he is feeling better.  I told him not to take the 3rd booster vaccine until he had been cleared to do so by his physician.   I also encouraged him to report this on VAERS and provided him with the website address.   I have alerted the Quality person of this event.  The evens that patient received were at our system's hospitals community events.
2 month old (child) infant sitting in car seat. She was found by mother unresponsive with mucous  secretions in mouth. Symptoms resolved within 1 minute.
Patient developed hives on the face.  treatment: Benadryl 12.5 mg po  Outcome: Hives subsided before discharge.
Hives on chest, neck, face and back--given oral Benadryl for itching.  Resolved by the next morning. No breathing problems, light headedness or abdominal complaints.  No history of egg allergy or prior allergic response to any other vaccine (including seasonal flumist vaccine one month earlier).  THE VACCINE GIVEN ON 11/20 was the H1N1 Flumist.
Suspected vaccination failure; Have them now. Second time; This case was reported by a consumer via media  and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient stated that the patient had Shingles at the time of reporting. It was second time and was vaccinated. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Swelling, redness, erythema at injection site.  Injection site was just above elbow, not at proper deltoid indicated site.
Pt calls about receiving her covid injection at County Line on 10/14/21. Still redness and swelling on her left arm where injection was given and feels hard and not warm to touch.  No streaking or pain.  No drainage or signs of infection.  Never fever today or yesterday.  Low grade fever Fri and Sat
w/in 4hr of vax pt devel an inj site rxn characterized by inflammation, swelling & pain which extended from the shoulder to wrist;tx w/applications of ice & heat & APAP;
This spontaneous case was reported by a physician and describes the occurrence of WRONG PRODUCT ADMINISTERED (inadvertently administered with the Moderna COVID-19 Vaccine Bivalent instead of the first dose of the primary series) and NO ADVERSE EVENT (No Adverse Event) in a 10-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     The patient's past medical history included Febrile seizure (febrile seizure when patient was younger). Previously administered products included for Drug use for unknown indication: flu shot (flu shot). Past adverse reactions to the above products included No adverse event with flu shot.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (inadvertently administered with the Moderna COVID-19 Vaccine Bivalent instead of the first dose of the primary series) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, WRONG PRODUCT ADMINISTERED (inadvertently administered with the Moderna COVID-19 Vaccine Bivalent instead of the first dose of the primary series) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (inadvertently administered with the Moderna COVID-19 Vaccine Bivalent instead of the first dose of the primary series).    No concomitant medication was reported. A 10 year old patient was inadvertently administered with the Moderna COVID-19 Vaccine Bivalent instead of the first dose of the primary series. HCP did not know the exact date of the administration because the vaccine was not administered in that facility. No treatment medication was reported.
Body Aches, chills, low grade fever, fatigue - treatment was rest  Lasted about afternoon of Monday (May 3) through the night.  Tuesday still had minor body aches and was tired.  Wednesday feel 100% now.
Went to bed the night I got my vaccine. Arm was itchy but not too bad.. Woke up on the middle of the night to intense itching. By morning my whole forearm was swollen and red and itchy. All the way from my wrist to my elbow. The injection site area grew to the size of a baseball.
She presented w/ N/V 8 days after vaccinations. Initial concern was pyloric stenosis -> neg U/S. Subsequently, on 10/18/13 developed status epilepticus. Was found to have bilateral subdural hematomas and bilateral retinal hemorrhages. 1st skeletal survey negative. 2 week FU concerning for rib fractures. Currently has intracranial shunt.
heat (L) arm; tingling (L) arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (heat (L) arm), PARAESTHESIA (tingling (L) arm) and FATIGUE (fatigue) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event reported). Concomitant products included Ibuprofen for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced INJECTION SITE WARMTH (heat (L) arm), PARAESTHESIA (tingling (L) arm) and FATIGUE (fatigue). At the time of the report, INJECTION SITE WARMTH (heat (L) arm), PARAESTHESIA (tingling (L) arm) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information include ibuprofen 2 doses.   Reporter did not allow further contact